|
Volumn 6, Issue 4, 2017, Pages
|
Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
|
Author keywords
acute heart failure; comparative effectiveness; diabetes mellitus; pharmacoepidemiology
|
Indexed keywords
ANTIDIABETIC AGENT;
BIOLOGICAL MARKER;
GLUCOSE BLOOD LEVEL;
GLYCOSYLATED HEMOGLOBIN;
HEMOGLOBIN A1C PROTEIN, HUMAN;
METFORMIN;
SULFONYLUREA DERIVATIVE;
AGED;
BLOOD;
COMPARATIVE STUDY;
DIABETES MELLITUS;
DRUG EFFECTS;
FACTUAL DATABASE;
FEMALE;
GLUCOSE BLOOD LEVEL;
GOVERNMENT;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
MALE;
MEDICAID;
MEDICARE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SEX DIFFERENCE;
TIME FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
VETERANS HEALTH;
AGED;
BIOMARKERS;
BLOOD GLUCOSE;
DATABASES, FACTUAL;
DIABETES MELLITUS;
FEMALE;
HEART FAILURE;
HEMOGLOBIN A, GLYCOSYLATED;
HOSPITALIZATION;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MEDICAID;
MEDICARE;
METFORMIN;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
RISK FACTORS;
SEX FACTORS;
SULFONYLUREA COMPOUNDS;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;
VETERANS HEALTH;
|
EID: 85029529182
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.116.005379 Document Type: Article |
Times cited : (85)
|
References (0)
|